Tech Company Financing Transactions
Dance Biopharm Funding Round
Dance Biopharm, operating out of San Francisco, raised $20.5 million in investment from Molex Ventures.
Transaction Overview
Company Name
Announced On
4/24/2019
Transaction Type
Venture Equity
Amount
$20,500,000
Round
Undisclosed
Investors
Molex Ventures (Lily Yeung)
Proceeds Purpose
The proceeds of the private placement will be used principally to fund manufacturing of the insulin and devices for Phase 3 registration studies for Dance 501, IND-enabling studies for Dance 601, a GLP-1 analog, organizational preparation for the execution of these studies, and general corporate purposes.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2 Mint Plz. 804
San Francisco, CA 94103
USA
San Francisco, CA 94103
USA
Phone
Website
Email Address
Overview
Dance Biopharm is focused on the development of inhaled insulin products to treat diabetes patients worldwide.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
John Patton
Chief Executive Officer
Anne Whitaker
Chief Financial Officer
Michael Kaseta
Vice President
Mei-chang Kuo
VP - Bus. Development
Melissa Rhodes
VP - Operations
Truc Le
Browse more venture capital transactions:
Prev: 4/24/2019: Sight Machine venture capital transaction
Next: 4/24/2019: Payrix venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document every notable VC transaction. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs